Drug Profile
PF 3864086
Alternative Names: PF-03864086; PF-3864086Latest Information Update: 28 Apr 2009
Price :
$50
*
At a glance
- Originator Pfizer
- Class Analgesics; Antipyretics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 31 Mar 2009 Discontinued - Phase-I for Pain in Belgium (PO)
- 31 Aug 2008 Phase-I clinical trials in Pain in Belgium (PO)